What is FENa and Why It Matters

Fractional excretion of sodium quantifies the percentage of filtered sodium that appears in urine. In healthy kidneys, this ratio remains tightly controlled. When acute kidney injury develops, the pattern shifts dramatically: preserved sodium reabsorption (low FENa) suggests the kidney is responding appropriately to poor perfusion, whilst excessive sodium wasting (high FENa) indicates direct kidney tissue damage.

FENa works because prerenal conditions trigger the kidney's natural conservation reflex—sodium and water are reabsorbed to restore circulating volume. Conversely, intrinsic renal damage impairs the tubular epithelium's ability to reabsorb sodium, causing it to spill into urine.

Key limitations exist: FENa is unreliable in chronic kidney disease, during diuretic use, in contrast-induced nephropathy, and with certain medications that suppress tubular sodium reabsorption. Clinicians must integrate FENa with clinical context rather than treating it as a definitive test in isolation.

FENa Calculation

FENa expresses the ratio of filtered sodium excretion to filtered creatinine excretion. The formula uses four laboratory measurements obtained simultaneously from serum (blood) and spot or 24-hour urine samples.

FENa (%) = (Urine Na / Serum Na) ÷ (Urine Cr / Serum Cr) × 100

  • Urine Na — Sodium concentration in urine (mmol/L)
  • Serum Na — Sodium concentration in blood plasma (mmol/L)
  • Urine Cr — Creatinine concentration in urine (mg/dL)
  • Serum Cr — Creatinine concentration in blood plasma (mg/dL)

Interpreting FENa Results

FENa values fall into three diagnostic categories:

  • FENa < 1%: Suggests prerenal aetiology. The kidney is underperfused (hypovolemia, cardiogenic shock, sepsis, renal artery stenosis) and responding by conserving sodium. Prognosis improves with restoration of renal perfusion.
  • FENa 1–4%: Indicates intrinsic renal damage. Acute tubular necrosis (ATN), acute interstitial nephritis (AIN), and glomerulonephritis destroy the tubular epithelium or filtering units, preventing normal sodium reabsorption.
  • FENa > 4%: Usually reflects postrenal obstruction. Urine backs up behind a blockage (kidney stones, prostate enlargement, ureteral ligation), causing high intratubular pressure that forces sodium into urine.

Overlap zones exist; a patient with prerenal injury superimposed on chronic kidney disease may show intermediate values. Always correlate with clinical presentation, imaging, and urine microscopy.

Required Laboratory Tests

Accurate FENa calculation requires simultaneous collection of serum and urine specimens within the same timeframe:

  • Serum Creatinine: Normal adult range 0.6–1.3 mg/dL. Reflects glomerular filtration rate and is filtered freely by the kidneys.
  • Serum Sodium: Normal range 136–145 mmol/L. Tightly regulated hormone-dependent electrolyte in blood plasma.
  • Urine Creatinine: Typical range 20–370 mg/dL in random samples; 24-hour urine collection yields 800–2000 mg. Remains relatively constant daily output per kilogram of body weight.
  • Urine Sodium: Normal 24-hour excretion 100–260 mmol/L. Spot urine values vary widely depending on dietary intake and fluid status.

A spot urine sample suffices for initial screening, though 24-hour collection provides more stable results. Timing is critical: serum and urine must be drawn within hours to minimise measurement error from physiological changes.

Clinical Pitfalls and Caveats

Several conditions and medications can invalidate FENa interpretation, making clinical correlation essential.

  1. Diuretic use masks the true picture — Loop and thiazide diuretics force sodium excretion regardless of renal perfusion status, elevating FENa artificially. A patient on furosemide with a high FENa may actually have prerenal disease. Always obtain FENa before initiating diuretics or exclude them from interpretation.
  2. Contrast-induced and rhabdomyolysis-related injury behaves atypically — Iodinated radiocontrast and myoglobin-induced AKI produce low FENa despite intrinsic tubular damage because of intense tubular swelling and obstruction. Clinical context (recent imaging, elevated creatine kinase) is required to recognise these exceptions.
  3. Chronic kidney disease confounds acute assessment — Patients with pre-existing reduced GFR may show intermediate FENa values even during an acute insult. Baseline creatinine must be known; compare acute values to recent steady-state levels. A rise in creatinine from 2.5 to 3.5 mg/dL still indicates acute change even if FENa suggests partial preservation.
  4. Hepatic and cardiac disease alter sodium handling — Cirrhosis and decompensated heart failure activate neurohumoral sodium-conservation mechanisms that lower FENa despite intrinsic renal injury. Critically ill patients may show mixed patterns. Urine osmolality and clinical exam (jugular venous pressure, ascites) provide essential context.

Frequently Asked Questions

What is the difference between FENa and fractional excretion of urea (FEUrea)?

FENa measures sodium handling and works best in intact kidneys without diuretic use. FEUrea (fractional excretion of urea) is an alternative metric less affected by diuretics and certain medications, making it useful when FENa is unreliable. Both have ~90% sensitivity for prerenal disease when properly applied, but FEUrea is gaining favour in practice because it remains valid even if patients are receiving diuretic therapy. Many nephrologists calculate both when diagnostic uncertainty exists.

Can FENa distinguish prerenal disease from acute interstitial nephritis?

FENa alone cannot reliably separate these conditions. Acute interstitial nephritis (AIN) from antibiotics or NSAIDs is intrinsic renal injury, producing FENa > 1%. However, it may present with preserved renal function and low urine sodium early in the course. Urine microscopy showing white blood cell casts or eosinophils, together with clinical history (medication exposure, rash, fever), is essential for AIN diagnosis. FENa indicates the mechanism of sodium wasting but does not identify the tissue-level pathology.

Why is FENa unreliable in chronic kidney disease patients?

Chronically reduced nephron mass alters baseline sodium reabsorption capacity and glomerular filtration. The kidney's response to acute perfusion changes becomes dampened. A patient with advanced chronic kidney disease experiencing acute prerenal injury may show FENa in the 1–2% range rather than clearly < 1%, obscuring the diagnosis. Serial creatinine trends and clinical volume assessment (physical exam, central venous pressure) become more important than a single FENa value in these patients.

What should be done if FENa falls between 1% and 4%?

An intermediate FENa (1–4%) indicates intrinsic renal damage but does not specify the cause. Examine urine sediment for casts (granular or muddy-brown suggests ATN; white cell casts suggest AIN). Check for recent contrast exposure, rhabdomyolysis markers, and medication history. Review renal ultrasound to exclude obstruction. Some overlap exists with prerenal disease in recovery phase or chronic kidney disease superimposed on acute injury. Clinical context and additional investigations guide management rather than relying solely on the FENa value.

How should I interpret FENa in patients with sepsis?

Sepsis creates a complex picture because it triggers both hypoperfusion (prerenal stimulus) and direct inflammatory tubular injury. FENa may be low (< 1%) early in septic shock when hypotension dominates, or elevated (> 2%) later as capillary leak and cytokine-mediated tubular dysfunction develop. Serial measurements along with lactate clearance, fluid responsiveness assessment, and urine microscopy are more informative than a single FENa in sepsis. Many sepsis-induced AKI cases show mixed features that do not fit neatly into traditional prerenal/intrinsic/postrenal categories.

Can I use FENa if the patient has been receiving ACE inhibitors or ARBs?

ACE inhibitors and angiotensin receptor blockers do not prevent FENa calculation but may lower serum creatinine and alter haemodynamic responses. These drugs dilate the efferent arteriole, reducing glomerular capillary pressure; in the setting of renal artery stenosis they can precipitate acute kidney injury. FENa remains valid mathematically, but the clinical interpretation requires understanding that the drug may have contributed to the decline in renal function. Always review medications and recent blood pressure changes when interpreting FENa results.

More health calculators (see all)